So what's your name, and what's your company about?

So my name is Erik van der Toorn, and I'm co-founder and CEO of HoloGenomics, where we are working on, on making it possible to do urine-based liquid biopsies.

Liquid biopsies is a new way of making sure that someone has, uh, like diagnosing or, um, like monitoring a cancer.

And this is actually, uh, b- doing this purely based on urine is super hard to do because it's very dilute there.

And with our technology, we actually make it possible to concentrate all that urine into exactly the molecule you need to then perform a test.

[laughs]

Uh, because [laughs] while tomorrow is a very ni- nice day, Hel- uh, I will not be attending Hello Tomorrow.

I am purely here for this lovely e- event where there's already a lot of networking going on, and I believe that, um, like, I will m- meet a lot of the people that I think are very relevant to me already here.